\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ notable\\ for\\ periumbilical\\ tenderness\\ with\\ some\\ radiation\\ of\\ pain\\ bilaterally\\,\\ the\\ abdomen\\ was\\ soft\\ without\\ rebound\\ or\\ guarding\\ and\\ the\\ physical\\ exam\\ was\\ otherwise\\ unremarkable\\.\ \(0\)\
\-\ initial\\ laboratory\\ values\\ were\\ notable\\ for\\ albumin\\ of\\ 3\\.4\\,\\ alk\\ phos\\ 310\\,\\ ast\\ 83\\,\\ alt\\ 125\\,\\ total\\ bilirubin\\ 4\\.3\\,\\ esr\\ 44\\,\\ ggt\\ 109\\.\\ the\\ patient\\ was\\ admitted\\ for\\ pain\\ control\\ and\\ observation\\.\\ \ \(0\)\
\-\ the\\ first\\ day\\ of\\ admission\\ the\\ patient\\ clinically\\ worsened\\;\\ he\\ became\\ febrile\\ with\\ increasing\\ total\\ bilirubin\\ to\\ 7\\.5\\ and\\ right\\ upper\\ quadrant\\ pain\\ radiating\\ to\\ the\\ right\\ shoulder\\ concerning\\ for\\ acute\\ cholecystitis\\.\\ the\\ patient\\ also\\ developed\\ apparent\\ scleral\\ icterus\\.\ \(0\)\
\-\ the\\ patient\\ then\\ underwent\\ ercp\\ with\\ stone\\ removal\\ that\\ revealed\\ a\\ purulent\\ gallbladder\\ and\\ common\\ bile\\ duct\\.\\ he\\ is\\ currently\\ on\\ antibiotics\\ in\\ anticipation\\ of\\ cholecystectomy\\ following\\ resolution\\ of\\ acute\\ infection\\.\\ \ \(0\)\
\-\ after\\ discharge\\ he\\ will\\ be\\ maintained\\ on\\ his\\ home\\ regimen\\ of\\ ursodiol\\,\\ hydroxyzine\\,\\ and\\ lansoprazol\\ as\\ well\\ as\\ tramadol\\ as\\ needed\\ for\\ abdominal\\ pain\\ until\\ seen\\ by\\ gastroenterology\\.\ \(0\)\
\-\ the\\ presentation\\ ultrasound\\ showed\\ an\\ enlarged\\ common\\ hepatic\\ duct\\ with\\ patchy\\ areas\\ of\\ increased\\ echogenicity\\ believed\\ to\\ represent\\ fatty\\ infiltration\\ versus\\ fibrosis\\.\ \(0\)\
\-\ ct\\ imaging\\ initially\\ showed\\ mild\\ dilatation\\ of\\ the\\ common\\ bile\\ duct\\ and\\ left\\ intrahepatic\\ bile\\ duct\\ with\\ enhancement\\ of\\ the\\ gallbladder\\ wall\\ and\\ common\\ bile\\ duct\\ suggestive\\ of\\ cholangitis\\.\\ \ \(0\)\
\-\ ercp\\ early\\ on\\ showed\\ stricture\\ formation\\ in\\ the\\ bile\\ ducts\\ with\\ the\\ classic\\ \\‚\\Ä\\úbeads\\ on\\ a\\ string\\‚\\Ä\\ù\\ appearance\\ with\\ dilation\\ of\\ the\\ common\\ bile\\ duct\\.\\ \ \(0\)\
\-\ mrcp\\ at\\ \\ this\\ presentation\\ showed\\ increased\\ stricture\\ formation\\ at\\ the\\ proximal\\ left\\ branch\\,\\ the\\ cystic\\ duct\\ near\\ junction\\ with\\ common\\ hepatic\\ duct\\,\\ and\\ diffuse\\ narrowing\\ of\\ the\\ common\\ bile\\ duct\\ with\\ more\\ dilation\\ of\\ the\\ common\\ hepatic\\ duct\\ than\\ previous\\ mrcp\\.\\ imaging\\ also\\ showed\\ stones\\ present\\ in\\ the\\ cystic\\ duct\\ proximal\\ to\\ the\\ area\\ of\\ narrowing\\ with\\ sludge\\ in\\ the\\ common\\ hepatic\\ duct\\ proximal\\ to\\ the\\ narrowed\\ common\\ bile\\ duct\\.\\ the\\ gallbladder\\ was\\ found\\ to\\ be\\ distended\\ and\\ thickwalled\\ with\\ a\\ moderate\\ amount\\ of\\ adjacent\\ edema\\ consistent\\ with\\ acute\\ cholecystitis\\.\\ progression\\ of\\ the\\ beaded\\ appearance\\ of\\ the\\ intrahepatic\\ bile\\ ducts\\ was\\ also\\ demonstrated\\.\ \(0\)\
\-\ acute\\ cholecystitis\\ in\\ the\\ setting\\ of\\ primary\\ sclerosing\\ cholangitis\ \(0\)\
\-\ \\‚\\Ä\\¢\\ primary\\ sclerosing\\ cholangitis\ \(0\)\
\-\ \\‚\\Ä\\¢\\ secondary\\ sclerosing\\ cholangitis\\:\\ \\ ascending\\ cholangitis\\ as\\ \\ result\\ of\\ strictures\\,\\ stones\\,\\ or\\ bile\\ duct\\ anomalies\ \(0\)\
\-\ \\‚\\Ä\\¢\\ cholangiocarcinoma\ \(0\)\
\-\ this\\ 18\\ year\\ old\\ man\\ presented\\ 2\\ years\\ prior\\ to\\ his\\ primary\\ care\\ physician\\ with\\ complaints\\ of\\ abdominal\\ pain\\,\\ fatigue\\,\\ and\\ dizziness\\ and\\ was\\ diagnosed\\ with\\ primary\\ sclerosing\\ cholangitis\\.\\ the\\ patient\\ did\\ well\\ with\\ an\\ appropriate\\ medication\\ regimen\\ and\\ frequent\\ gi\\ follow\\ up\\ until\\ approximately\\ 2\\ years\\ after\\ diagnosis\\ when\\ he\\ presented\\ with\\ fatigue\\,\\ diarrhea\\,\\ and\\ abdominal\\ pain\\ \\-\\ unrelieved\\ by\\ tramadol\\.\ \(0\)\
\-\ the\\ patient\\ was\\ diagnosed\\ with\\ psc\\ based\\ on\\ initial\\ imaging\\ findings\\,\\ laboratory\\ values\\,\\ and\\ liver\\ biopsy\\ results\\ showed\\ mild\\ chronic\\ inflammation\\ of\\ the\\ portal\\ tract\\ without\\ evidence\\ of\\ sclerosing\\ acute\\ cholecystitis\\ was\\ diagnosed\\ with\\ imaging\\,\\ laboratory\\ values\\ and\\ clinical\\ examination\\ findings\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ duct\\:\\ 0\\.10733366093193387\ \(0\)\
\-\ bile\\:\\ 0\\.08937423056589312\ \(0\)\
\-\ cholangitis\\:\\ 0\\.06619332203857399\ \(0\)\
\-\ sclerosing\\:\\ 0\\.049455169356878034\ \(0\)\
\-\ common\\:\\ 0\\.04376256774865748\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.035529176555385074\ \(0\)\
\-\ showed\\:\\ 0\\.03289788572904536\ \(0\)\
\-\ hepatic\\:\\ 0\\.027933419583608704\ \(0\)\
\-\ tramadol\\:\\ 0\\.02749025031208784\ \(0\)\
\-\ values\\:\\ 0\\.025081547798609556\ \(0\)\
\-\ mrcp\\:\\ 0\\.02446406679649691\ \(0\)\
\-\ gallbladder\\:\\ 0\\.024105606003840496\ \(0\)\
\-\ ercp\\:\\ 0\\.02240499401412204\ \(0\)\
\-\ regimen\\:\\ 0\\.020938483448793625\ \(0\)\
\-\ acute\\:\\ 0\\.020644611830787623\ \(0\)\
\-\ bilirubin\\:\\ 0\\.020164214394664783\ \(0\)\
\-\ primary\\:\\ 0\\.019815141001140478\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.019692089197840455\ \(0\)\
\-\ ducts\\:\\ 0\\.019191762890561063\ \(0\)\
\-\ he\\:\\ 0\\.018662914614739876\ \(0\)\
\-\ laboratory\\:\\ 0\\.018487818410102146\ \(0\)\
\-\ notable\\:\\ 0\\.018478175584126802\ \(0\)\
\-\ diagnosed\\:\\ 0\\.01844732968764191\ \(0\)\
\-\ stricture\\:\\ 0\\.0179311621110342\ \(0\)\
\-\ fatigue\\:\\ 0\\.017874846113178626\ \(0\)\
\-\ was\\:\\ 0\\.017406062035074717\ \(0\)\
\-\ 109\\.\\:\\ 0\\.01725150376510078\ \(0\)\
\-\ ursodiol\\:\\ 0\\.01725150376510078\ \(0\)\
\-\ hydroxyzine\\:\\ 0\\.01725150376510078\ \(0\)\
\-\ lansoprazol\\:\\ 0\\.01725150376510078\ \(0\)\
\-\ stones\\:\\ 0\\.017208132352915458\ \(0\)\
\-\ anticipation\\:\\ 0\\.015895051356959986\ \(0\)\
\-\ thickwalled\\:\\ 0\\.015895051356959986\ \(0\)\
\-\ dilation\\:\\ 0\\.015765270767845216\ \(0\)\
\-\ imaging\\:\\ 0\\.015671810758947965\ \(0\)\
\-\ 310\\:\\ 0\\.015101577564184713\ \(0\)\
\-\ psc\\:\\ 0\\.015101577564184713\ \(0\)\
\-\ proximal\\:\\ 0\\.015061897348573473\ \(0\)\
\-\ until\\:\\ 0\\.014688545561407166\ \(0\)\
\-\ unrelieved\\:\\ 0\\.014538598948819191\ \(0\)\
\-\ total\\:\\ 0\\.014402035173840455\ \(0\)\
\-\ formation\\:\\ 0\\.01380528921045778\ \(0\)\
\-\ ggt\\:\\ 0\\.01374512515604392\ \(0\)\
\-\ narrowing\\:\\ 0\\.013410750270645781\ \(0\)\
\-\ beads\\:\\ 0\\.013182146540678398\ \(0\)\
\-\ beaded\\:\\ 0\\.013182146540678398\ \(0\)\
\-\ 7\\.5\\:\\ 0\\.012745466401120259\ \(0\)\
\-\ gastroenterology\\:\\ 0\\.012745466401120259\ \(0\)\
\-\ icterus\\:\\ 0\\.012558949415201815\ \(0\)\
\-\ abdominal\\:\\ 0\\.01253964327664647\ \(0\)\
\-\ pain\\:\\ 0\\.012253716252807061\ \(0\)\
\-\ scleral\\:\\ 0\\.012232033398248455\ \(0\)\
\-\ 125\\:\\ 0\\.011951992608344985\ \(0\)\
\-\ presentation\\:\\ 0\\.01152015903910404\ \(0\)\
\-\ periumbilical\\:\\ 0\\.011389013992979466\ \(0\)\
\-\ string\\:\\ 0\\.011293534219653767\ \(0\)\
\-\ 3\\.4\\:\\ 0\\.01120249700706102\ \(0\)\
\-\ purulent\\:\\ 0\\.01120249700706102\ \(0\)\
\-\ initial\\:\\ 0\\.011082513280936625\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.010952333853421325\ \(0\)\
\-\ sludge\\:\\ 0\\.010952333853421325\ \(0\)\
\-\ strictures\\:\\ 0\\.010952333853421325\ \(0\)\
\-\ albumin\\:\\ 0\\.010801725162352581\ \(0\)\
\-\ \\,\\:\\ 0\\.010595305891087568\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.01053137224947427\ \(0\)\
\-\ maintained\\:\\ 0\\.010469241724396812\ \(0\)\
\-\ 83\\:\\ 0\\.01018512820219623\ \(0\)\
\-\ as\\:\\ 0\\.010118023529503936\ \(0\)\
\-\ narrowed\\:\\ 0\\.010082107197332392\ \(0\)\
\-\ patient\\:\\ 0\\.01005783089138616\ \(0\)\
\-\ believed\\:\\ 0\\.010032561584838671\ \(0\)\
\-\ also\\:\\ 0\\.009890134600803237\ \(0\)\
\-\ years\\:\\ 0\\.009820912473653551\ \(0\)\
\-\ alk\\:\\ 0\\.009759054848292373\ \(0\)\
\-\ phos\\:\\ 0\\.009759054848292373\ \(0\)\
\-\ cystic\\:\\ 0\\.009646311965760306\ \(0\)\
\-\ his\\:\\ 0\\.009639487388050615\ \(0\)\
\-\ febrile\\:\\ 0\\.009635417076038887\ \(0\)\
\-\ appearance\\:\\ 0\\.009565192081153195\ \(0\)\
\-\ worsened\\:\\ 0\\.009206740821513085\ \(0\)\
\-\ \\‚\\Ä\\¢\\:\\ 0\\.00919969286651206\ \(0\)\
\-\ presented\\:\\ 0\\.009116859628267747\ \(0\)\
\-\ infiltration\\:\\ 0\\.00911278931625602\ \(0\)\
\-\ ast\\:\\ 0\\.00908244844240873\ \(0\)\
\-\ alt\\:\\ 0\\.00908244844240873\ \(0\)\
\-\ guarding\\:\\ 0\\.009052570806144956\ \(0\)\
\-\ branch\\:\\ 0\\.009052570806144956\ \(0\)\
\-\ became\\:\\ 0\\.0090231424747075\ \(0\)\
\-\ echogenicity\\:\\ 0\\.00899415013461916\ \(0\)\
\-\ radiating\\:\\ 0\\.0089655810555171\ \(0\)\
\-\ patchy\\:\\ 0\\.0089655810555171\ \(0\)\
\-\ ascending\\:\\ 0\\.0089655810555171\ \(0\)\
\-\ dizziness\\:\\ 0\\.0089655810555171\ \(0\)\
\-\ cholecystectomy\\:\\ 0\\.008937423056589313\ \(0\)\
\-\ mild\\:\\ 0\\.008807254222822454\ \(0\)\
\-\ portal\\:\\ 0\\.00880240765250526\ \(0\)\
\-\ concerning\\:\\ 0\\.00877648744360111\ \(0\)\
\-\ rebound\\:\\ 0\\.00875090607067087\ \(0\)\
\-\ anomalies\\:\\ 0\\.00875090607067087\ \(0\)\
\-\ fatty\\:\\ 0\\.008676109176697878\ \(0\)\
\-\ diarrhea\\:\\ 0\\.008676109176697878\ \(0\)\
\-\ 44\\:\\ 0\\.00858062940337218\ \(0\)\
\-\ observation\\:\\ 0\\.00858062940337218\ \(0\)\
\-\ esr\\:\\ 0\\.008467479558188568\ \(0\)\
\-\ setting\\:\\ 0\\.008445613999288127\ \(0\)\
\-\ medication\\:\\ 0\\.00842399005371751\ \(0\)\
\-\ frequent\\:\\ 0\\.008360515932869851\ \(0\)\
\-\ stone\\:\\ 0\\.008319315523480747\ \(0\)\
\-\ progression\\:\\ 0\\.008319315523480747\ \(0\)\
\-\ physical\\:\\ 0\\.008205500076638898\ \(0\)\
\-\ increased\\:\\ 0\\.008181936523677713\ \(0\)\
\-\ discharge\\:\\ 0\\.008107024636995287\ \(0\)\
\-\ distended\\:\\ 0\\.008088820346070995\ \(0\)\
\-\ home\\:\\ 0\\.007948978929276191\ \(0\)\
\-\ versus\\:\\ 0\\.007948978929276191\ \(0\)\
\-\ physician\\:\\ 0\\.007882635383922608\ \(0\)\
\-\ appropriate\\:\\ 0\\.007882635383922608\ \(0\)\
\-\ without\\:\\ 0\\.007874806913339178\ \(0\)\
\-\ the\\:\\ 0\\.00784584981683982\ \(0\)\
\-\ control\\:\\ 0\\.007623361053108362\ \(0\)\
\-\ well\\:\\ 0\\.007565874571305874\ \(0\)\
\-\ gi\\:\\ 0\\.00751229878971805\ \(0\)\
\-\ fibrosis\\:\\ 0\\.007445955244364466\ \(0\)\
\-\ tract\\:\\ 0\\.007407202549068615\ \(0\)\
\-\ apparent\\:\\ 0\\.007394453662530076\ \(0\)\
\-\ admission\\:\\ 0\\.007369202381050805\ \(0\)\
\-\ exam\\:\\ 0\\.0073472952639903645\ \(0\)\
\-\ represent\\:\\ 0\\.007344272780703583\ \(0\)\
\-\ clinically\\:\\ 0\\.007331926069953555\ \(0\)\
\-\ needed\\:\\ 0\\.0072833037635219875\ \(0\)\
\-\ 18\\:\\ 0\\.007259438258446022\ \(0\)\
\-\ complaints\\:\\ 0\\.007259438258446022\ \(0\)\
\-\ near\\:\\ 0\\.0072358602965748395\ \(0\)\
\-\ admitted\\:\\ 0\\.0072241769952313874\ \(0\)\
\-\ resolution\\:\\ 0\\.007212563031396134\ \(0\)\
\-\ 2\\:\\ 0\\.007201974546029535\ \(0\)\
\-\ dilatation\\:\\ 0\\.007166784402091426\ \(0\)\
\-\ suggestive\\:\\ 0\\.00714429050889038\ \(0\)\
\-\ for\\:\\ 0\\.007134130612942418\ \(0\)\
\-\ findings\\:\\ 0\\.00711873556082176\ \(0\)\
\-\ inflammation\\:\\ 0\\.007111027150047775\ \(0\)\
\-\ on\\:\\ 0\\.007083082312773268\ \(0\)\
\-\ junction\\:\\ 0\\.007004063524729058\ \(0\)\
\-\ amount\\:\\ 0\\.006983354895902176\ \(0\)\
\-\ after\\:\\ 0\\.006919769873225841\ \(0\)\
\-\ increasing\\:\\ 0\\.006853840401026831\ \(0\)\
\-\ initially\\:\\ 0\\.0068062237656852835\ \(0\)\
\-\ results\\:\\ 0\\.006750572228854494\ \(0\)\
\-\ shoulder\\:\\ 0\\.006741448915535881\ \(0\)\
\-\ currently\\:\\ 0\\.0066265612426850435\ \(0\)\
\-\ removal\\:\\ 0\\.006592526521135397\ \(0\)\
\-\ moderate\\:\\ 0\\.006575728588275531\ \(0\)\
\-\ previous\\:\\ 0\\.006493836005231499\ \(0\)\
\-\ developed\\:\\ 0\\.006438484314745038\ \(0\)\
\-\ result\\:\\ 0\\.006415233183851197\ \(0\)\
\-\ classic\\:\\ 0\\.006407543794144955\ \(0\)\
\-\ based\\:\\ 0\\.006377084857665284\ \(0\)\
\-\ antibiotics\\:\\ 0\\.006281245318337575\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.006245598664929862\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.006210589731953786\ \(0\)\
\-\ early\\:\\ 0\\.00611577097777385\ \(0\)\
\-\ did\\:\\ 0\\.006038001254389283\ \(0\)\
\-\ care\\:\\ 0\\.006031657822052353\ \(0\)\
\-\ otherwise\\:\\ 0\\.006006487736646467\ \(0\)\
\-\ then\\:\\ 0\\.0059510115037614275\ \(0\)\
\-\ biopsy\\:\\ 0\\.005932863486569003\ \(0\)\
\-\ quadrant\\:\\ 0\\.0058852758003640985\ \(0\)\
\-\ to\\:\\ 0\\.005850248060862825\ \(0\)\
\-\ liver\\:\\ 0\\.005765599825504351\ \(0\)\
\-\ underwent\\:\\ 0\\.00573815271130767\ \(0\)\
\-\ enlarged\\:\\ 0\\.005705716380399229\ \(0\)\
\-\ areas\\:\\ 0\\.005626902487761383\ \(0\)\
\-\ first\\:\\ 0\\.005611513571009495\ \(0\)\
\-\ by\\:\\ 0\\.005568966353208903\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0055363335003562825\ \(0\)\
\-\ bilaterally\\:\\ 0\\.005492573852297266\ \(0\)\
\-\ radiation\\:\\ 0\\.005487771525562302\ \(0\)\
\-\ revealed\\:\\ 0\\.00536687649680253\ \(0\)\
\-\ follow\\:\\ 0\\.005313501902047816\ \(0\)\
\-\ day\\:\\ 0\\.005309119039829608\ \(0\)\
\-\ area\\:\\ 0\\.005287350771299935\ \(0\)\
\-\ adjacent\\:\\ 0\\.005287350771299935\ \(0\)\
\-\ and\\:\\ 0\\.005284021694683516\ \(0\)\
\-\ found\\:\\ 0\\.0052701088345442505\ \(0\)\
\-\ will\\:\\ 0\\.005231861092718477\ \(0\)\
\-\ examination\\:\\ 0\\.005198479521476644\ \(0\)\
\-\ approximately\\:\\ 0\\.005173811793650847\ \(0\)\
\-\ be\\:\\ 0\\.00515756056103299\ \(0\)\
\-\ clinical\\:\\ 0\\.005145420352379655\ \(0\)\
\-\ tenderness\\:\\ 0\\.005085934095658774\ \(0\)\
\-\ some\\:\\ 0\\.005078137483105203\ \(0\)\
\-\ diffuse\\:\\ 0\\.005062636830480068\ \(0\)\
\-\ of\\:\\ 0\\.005015819212437858\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0049611009491317085\ \(0\)\
\-\ abdomen\\:\\ 0\\.0049537852502851195\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004906888419680954\ \(0\)\
\-\ infection\\:\\ 0\\.00486108918605246\ \(0\)\
\-\ wall\\:\\ 0\\.00484375561690557\ \(0\)\
\-\ when\\:\\ 0\\.004789297920970657\ \(0\)\
\-\ following\\:\\ 0\\.0047461404244640865\ \(0\)\
\-\ edema\\:\\ 0\\.004729791564444796\ \(0\)\
\-\ chronic\\:\\ 0\\.004710351532107632\ \(0\)\
\-\ secondary\\:\\ 0\\.00467520541391156\ \(0\)\
\-\ an\\:\\ 0\\.004624911406202465\ \(0\)\
\-\ at\\:\\ 0\\.00453136263339191\ \(0\)\
\-\ up\\:\\ 0\\.004496765461945642\ \(0\)\
\-\ enhancement\\:\\ 0\\.004482365491434512\ \(0\)\
\-\ evidence\\:\\ 0\\.004384427756099565\ \(0\)\
\-\ than\\:\\ 0\\.004381700303166876\ \(0\)\
\-\ prior\\:\\ 0\\.004293762763605408\ \(0\)\
\-\ more\\:\\ 0\\.004182341114113828\ \(0\)\
\-\ in\\:\\ 0\\.004123260568887034\ \(0\)\
\-\ with\\:\\ 0\\.004121477827041126\ \(0\)\
\-\ consistent\\:\\ 0\\.004100388001626621\ \(0\)\
\-\ soft\\:\\ 0\\.004072263726014775\ \(0\)\
\-\ upper\\:\\ 0\\.004035382593676552\ \(0\)\
\-\ \\;\\:\\ 0\\.003963642247461045\ \(0\)\
\-\ man\\:\\ 0\\.0039548568357925615\ \(0\)\
\-\ or\\:\\ 0\\.00391985420338046\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003839959551429393\ \(0\)\
\-\ were\\:\\ 0\\.0037970378408804717\ \(0\)\
\-\ present\\:\\ 0\\.0037769251544651286\ \(0\)\
\-\ this\\:\\ 0\\.0037617894845954325\ \(0\)\
\-\ left\\:\\ 0\\.003742094987369529\ \(0\)\
\-\ \\-\\:\\ 0\\.0035845958096054078\ \(0\)\
\-\ right\\:\\ 0\\.003528891229394977\ \(0\)\
\-\ seen\\:\\ 0\\.003304555019701938\ \(0\)\
\-\ that\\:\\ 0\\.002888416298549556\ \(0\)\
\-\ ct\\:\\ 0\\.0023391460927437236\ \(0\)\
\-\ a\\:\\ 0\\.002328374570363608\ \(0\)\
\-\ \\:\\:\\ 0\\.0022118880939151955\ \(0\)\
\-\ year\\:\\ 0\\.0018710474936847645\ \(0\)\
\-\ old\\:\\ 0\\.0017122007766384628\ \(0\)\
\-\ \\.\\:\\ 0\\.0011810021793637704\ \(0\)\
\-\ is\\:\\ 0\\.0011003733432186412\ \(0\)\
